The research-driven pharmaceutical company Boehringer Ingelheim has been committed to innovative medicines for people and animals for more than 130 years. It is among the twenty largest companies in the pharmaceutical industry and is still a family business to this day. The company achieved a turnover of €15.9 billion in 2016, almost 20% of which was spent on research and development. The company is socially responsible and has a very diverse workforce. In addition, they place a strong focus on environmental protection and sustainability.